Rheumatologic Disorders In Pregnancy
From Anvita Health Wiki
Contents |
Complications
- increased risk of pre-eclampsia/eclampsia [1]
- anti- rheumatic agents, especially DMARDs may be teratogenic
Management
- preconception counseling in necessary
- fertility of women with rheumatoid arthritis is compartable to normal patients
- 75% of women with rheumatoid arthritis experience spontaneous remission of symptoms, generally beginning in the second trimester
- most women can safely discontinue therapy for rheumatoid arthritis during pregnancy
- low-dose prednisone, hydroxychloroquine & sulfasalazine may be used during pregnancy if necessary
- NSAIDs may be continued during the first & second trimesters but should be discontinued in the third trimester because of the risk of premature closure of the ductus arteriosus in utero
- TNF alpha inhibitors should be discontinued prior to conception (safety data insufficient)
- most pregnant women with rheumatoid arthritis experience a flare after delivery, thus DMARD therapy should be restarted immediately after delivery unless the woman is breastfeeding
- with severe rheumatoid arthritis, breastfeeding should be avoided & DMARD therapy restarted
More General Terms
Additional Terms
References
- Journal Watch 24(14):115, 2004 Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004 Jun;103(6):1190-3. PMID: [1]
- Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
